Pharmacokinetic study of niosome-loaded insulin in diabetic rats

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 6, 2011, Pages 404-411

  Pardakhty, A ^a   Moazeni, E ^b   Varshosaz, J ^c   Hajhashemi, V ^c   Rouholamini Najafabadi, A ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Protein delivery; Release; Vesicle size analysis

Indexed keywords

BILE SALT; BRIJ 92; CETOMACROGOL; CHOLESTEROL; CHYMOTRYPSIN A; INSULIN; NIOSOME; NONIONIC SURFACTANT; PEPSIN A; RECOMBINANT HUMAN INSULIN; SORBITAN STEARATE; STREPTOZOCIN; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INTESTINE FLUID; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; STOMACH JUICE; STREPTOZOCIN DIABETES; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84857419625     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sonaje K, Chen YJ, Chen HL, Wey SP, Juang JH, Nguyen HN, et al. Enteric-coated capsules filled with freeze-dried chitosan/poly ([gamma]-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials. 2010; 31: 3384-94.
2. Whitehead K, Shen Z, Mitragotri S. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. J Control Release. 2004; 98: 37-45.
3. Wu Z, Ping Q, Wei Y, Lai J. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacol Sin. 2004; 25: 966-72.
4. Zhang N, Ping QN, Huang GH, Xu WF. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm. 2005; 294: 247-59.
5. Sajeesh S, Bouchemal K, Marsaud V, Vauthier C, Sharma CP. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin. J Control Release. 2010; 147: 377-84.
6. Sharma G, Wilson K, van der Walle C, Sattar N, Petrie J, Ravi Kumar M. Microemulsions for oral delivery of insulin: Design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm. 2010; 76: 159-69.
7. Yamagata T, Morishita M, Kavimandan NJ, Nakamura K, Fukuoka Y, Takayama K, et al. Characterization of insulin protection properties of complexation hydrogels in gastric and intestinal enzyme fluids. J Control Release. 2006; 112: 343-9.
8. Sonaje K, Lin KJ, Wey SP, Lin CK, Yeh TH, Nguyen HN, et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-Responsive nanoparticles vs. subcutaneous injection. Biomaterials. 2010; 31: 6849-58.
9. Dorkoosh F, Verhoef JC, Borchard G, Rafiee-Tehrani M, Verheijden J, Junginger H. Intestinal absorption of human insulin in pigs using delivery systems based on superporous hydrogel polymers. Int J Pharm. 2002; 247: 47-55.
10. Moazeni E, Gilani K, Sotoudegan F, Pardakhty A, Najafabadi AR, Ghalandari R, et al. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J Microencapsul. 2010: 1-10.
11. Khaksa G, D'Souza R, Lewis S, Udupa N. Pharmacokinetic study of niosome encapsulated insulin. Indian J Exp Biol. 2000; 38: 901.
12. Ning M, Guo Y, Pan H, Yu H, Gu Z. Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: Studies in rats. Drug Deliv. 2005; 12: 399-407.
13. Varshosaz J, Pardakhty A, Hajhashemi V, Najafabadi AR. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv. 2003; 10: 251-62.
14. Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007; 328: 130-41.
15. Chattaraj S, Das S. Physicochemical characterization of influenza viral vaccine loaded surfactant vesicles. Drug Deliv. 2003; 10: 73-7.
16. Dong C, Rogers J. Quantitative determination of carboxymethyl chitin in polymer-coated liposomes. J Microencapsul. 1991; 8: 153-60.
17. Kisel M, Kulik L, Tsybovsky I, Vlasov A, Vorob Yov M, Kholodova E, et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int J Pharm. 2001; 216: 105-14.
18. Kim A, Yun MO, Oh YK, Ahn WS, Kim CK. Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. Int J Pharm. 1999; 180: 75-81.
19. Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994; 105: 1-6.
20. Hao YM, Li K. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Int J Pharm. 2011; 403: 245-53.
21. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008; 361: 104-11.
22. Arunothayanun P, Turton JA, Uchegbu IF, Florence AT. Preparation and in vitro/in vivo evaluation of luteinizing hormone releasing hormone (LHRH) loaded polyhedral and spherical/tubular niosomes. J Pharm Sci. 1999; 88: 34-8.
23. De la Maza A, Parra J, Sanchez Leal J. Alteration of permeability of neutral and electronegatively charged liposomes by alkyl sulfate surfactants. Langmuir. 1992; 8: 2422-6.
24. Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci. 2010; 99: 2049-60.
25. Fritzler M, behmanesh F, Fritzler M. Development of a depofoam technology for the sustained delivery of desferrioxamine mesylate. DARU. 2003; 11: 88-94.
26. Liu T, Guo R, Hua W, Qiu J. Structure behaviors of hemoglobin in PEG 6000/Tween 80/Span 80/H2O niosome system. Colloids Surf A. 2007; 293: 255-61.